Eastern Mediterranean Health Journal, Vol. 22 No. 2, 2016
Trilingual edition English/French/Arabic
WHO Regional Office for the Eastern Mediterranean
EMRO
WHO Regional Office for the Eastern Mediterranean
Order Number    04502202 Format    Paper Back
Price    CHF    20.00 / US$    24.00 Developing countries:    CHF    14.00
.     2016        72   pages
Summary
Table of contents
Related Publications
Translation(s) available
 
 
   Add to your order
 
 
Summary
The EMHJ was launched in 1995 as a peer-reviewed medical journal. Starting January 2010, the Journal has been given a new format and is now published monthly. The EMHJ serves as a forum for the dissemination of biomedical information through the publication of scientific research papers on a range of topics related to public health, with particular relevance to the Eastern Mediterranean Region.

In this month's issue: Closing the knowledge gaps on MERS: three and half years since its detection, what have we learnt and what needs to be done urgently?; Evaluation of factors associated with failure of tuberculosis treatment under DOTS in northern Islamic Republic of Iran; Epidemiology of tuberculosis and evaluation of treatment outcomes in the national tuberculosis control programme, River Nile state, Sudan, 2011?2013; Descriptive epidemiology of physical activity among Omani adults: the Oman World Health Survey, 2008; Exploring the characteristics of public reproductive health services in the Islamic Republic of Iran from the perspectives of unmarried women: what needs to be changed?; Men?s perceptions of and participation in family planning in Aqaba and Ma?an governorates, Jordan; Mesure de la qualité de vie en relation avec la santé chez la population de Tétouan (Maroc) à l?aide du SF-36 : données normatives et influence du sexe et de l'âge; Isolation frequency and susceptibility pattern of non-O1 and non-O139 Vibrio cholerae in a tertiary health care laboratory, 1999?2012; Evaluating the English language scientific writing skills of Saudi dental students at entry level; Good governance for medicines: moving towards a national framework; Antimicrobial resistance: implementing the global action plan in the Region.